Allos Therapeutics, Inc. (ALTH) and Mundipharma AG Announce Strategic Collaboration for FOLOTYN; Allos to Receive $50 Million Upfront; Potentially up to $310.5 Million
5/11/2011 6:52:33 AM
More...
|
Skyepharma PLC (SKYE) - Re Agreement
3/31/2009 12:46:13 PM
More...
|
Skyepharma PLC (SKYE) Research Update
1/21/2009 10:18:47 AM
More...
|
Sosei Group Corporation Announces Buyback of the Commercialization Rights to AD 923 from Mundipharma AG
12/29/2008 6:59:33 AM
More...
|
Mundipharma AG New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
9/26/2007 9:06:53 AM
More...
|
Skyepharma PLC (SKYE): $80 Million European Development And Marketing Agreement For Novel Pain Control Agent DepoBupivacaine(TM)
10/19/2005 5:13:08 PM
More...
|
Skyepharma PLC's (SKYE) Partner Mundipharma International Holdings Limited Launches DepoCyte In Europe
10/19/2005 5:09:56 PM
More...
|